Inovio Pharmaceuticals, Inc. (NYSE: INO) reported Q1 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.08 million.

For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.

Earnings